Association between time to progression and subsequent survival inceritinib-treated patients with advanced ALK-positive non-small-cell lung cancer
Current Medical Research and Opinion, 2016 11; 32(11): 1911-1918. e-pub ahead of print 2016/08/05; doi: 10.1080/03007995.2016.1220934
Authors
Liu G, Zhang J, Zhou ZY, Li J, Cai X, Signorovitch J